Barclays »

Fibrobiologics shares owned by Barclays

Quarter-by-quarter ownership of Fibrobiologics (FBLG) shares owned by Barclays from 13F filings

Historical chart of Barclays investment in Fibrobiologics

Tip: Access up to 7 years of quarterly data

All positions including Fibrobiologics held by Barclays consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Fibrobiologics by Barclays

Quarter filed Position value Share count Share price at filing
2026-06-30 $6.9k 7.2k 0.95

More positions owned by Barclays

STATE STR SPDR S&ampP 500 ETF T Fund (SPY)
Ishares Tr Opt Call Option (EEM)
Microsoft Corp Opt Call Option (MSFT)
Invesco Qqq Tr Fund (QQQ)
Ishares Tr Fund (IWM)
Nvidia Corporation Opt Call Option (NVDA)
Micron Technology (MU)
Apple (AAPL)
Alphabet Inc Class A cs (GOOGL)
Amazon Opt Put Option (AMZN)
Vaneck Etf Trust Opt Put Option (SMH)
Tesla Motors (TSLA)
Advanced Micro Devices Opt Put Option (AMD)
Broadcom Opt Put Option (AVGO)
Ishares Tr Opt Call Option (HYG)

View all positions for Barclays

Top funds holding Fibrobiologics

Cascade Financial Partners
Fund Evaluation Group
Geode Capital Management
Vanguard Capital Management
Qube Research & Technologies
BlackRock
Barclays
Vanguard Fiduciary Trust
Tower Research Capital
Advisor Group Holdings
Royal Bank of Canada
UBS Group
Islay Capital Management
Coconut Grove Bank
Bnp Paribas Arbitrage, Snc

View all funds holding Fibrobiologics